1. Home
  2. NGVT vs XNCR Comparison

NGVT vs XNCR Comparison

Compare NGVT & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ingevity Corporation

NGVT

Ingevity Corporation

N/A

Current Price

$59.90

Market Cap

2.4B

Sector

Industrials

ML Signal

N/A

Logo Xencor Inc.

XNCR

Xencor Inc.

N/A

Current Price

$35.82

Market Cap

2.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NGVT
XNCR
Founded
1964
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.0B
IPO Year
2015
2013

Fundamental Metrics

Financial Performance
Metric
NGVT
XNCR
Price
$59.90
$35.82
Analyst Decision
Strong Buy
Buy
Analyst Count
3
14
Target Price
★ $89.00
$41.58
AVG Volume (30 Days)
293.3K
★ 1.7M
Earning Date
11-04-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
61.10
★ 65.36
EPS
★ 4.08
N/A
Revenue
★ $1,167,600,000.00
$125,576,000.00
Revenue This Year
N/A
$18.52
Revenue Next Year
$1.74
N/A
P/E Ratio
$18.07
★ N/A
Revenue Growth
N/A
★ 13.65
52 Week Low
$46.38
$10.38
52 Week High
$79.29
$35.05

Technical Indicators

Market Signals
Indicator
NGVT
XNCR
Relative Strength Index (RSI) 25.62 77.02
Support Level N/A $11.05
Resistance Level $77.21 N/A
Average True Range (ATR) 2.66 2.04
MACD -0.98 0.92
Stochastic Oscillator 2.65 96.83

Price Performance

Historical Comparison
NGVT
XNCR

About NGVT Ingevity Corporation

Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through three segments, namely Performance Chemicals, Advanced Polymer Technologies, and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals that find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focuses on automotive carbon products used in automobiles. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers. The company generates the majority of its revenue from North America.

About XNCR Xencor Inc.

Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.

Share on Social Networks: